<DOC>
	<DOC>NCT01974024</DOC>
	<brief_summary>The aims of this study were to investigate the feasibility of methylprednisolone rotation as treatment of DIH</brief_summary>
	<brief_title>Randomize Controlled Phase 3, Cross-over Trial of Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation</brief_title>
	<detailed_description />
	<mesh_term>Hiccup</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>all solid cancer patients on chemotherapy age &gt;18 years received dexamethasone as an antiemetic brain metastases hiccups before dexamethasone administration uncontrolled diabetes mellitus uncontrolled esophagitis or peptic ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Hiccup</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Methylprednisolone</keyword>
</DOC>